MD237G2 - Hydrogel "Enzaprogel" for collum uterus maturing - Google Patents

Hydrogel "Enzaprogel" for collum uterus maturing

Info

Publication number
MD237G2
MD237G2 MD95-0176A MD950176A MD237G2 MD 237 G2 MD237 G2 MD 237G2 MD 950176 A MD950176 A MD 950176A MD 237 G2 MD237 G2 MD 237G2
Authority
MD
Moldova
Prior art keywords
collum
maturing
uterus
enzaprogel
preparation
Prior art date
Application number
MD95-0176A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD237F1 (en
Inventor
Еуджен ДЮГ
Valentina Diug
Ion Trigubenco
Original Assignee
Intreprinderea Individuala "Medifarm-Diug"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreprinderea Individuala "Medifarm-Diug" filed Critical Intreprinderea Individuala "Medifarm-Diug"
Priority to MD95-0176A priority Critical patent/MD237G2/en
Publication of MD237F1 publication Critical patent/MD237F1/en
Publication of MD237G2 publication Critical patent/MD237G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine, especially to the remedies influencing on muscles of uterus.The preparation “Enzaprogel” contains as active substance prostaglandin and as a carrier methyl-cellylose, polyvinyl pyrollidon and water for infections at the following ratio of components (mass %):Determination of optimal component's ratio and their limits is leaded at the following parameters: dynamic viscosity, adhesiveness, pharmaceutical accessibility, and degree of collum uteris maturing.The offered preparation, as it were shown by preliminary investigations, provides effective maturing of collum uterus at small dose of prostaglandine having in addition prolonged action during 24-30 hours without side effects.
MD95-0176A 1995-01-20 1995-01-20 Hydrogel "Enzaprogel" for collum uterus maturing MD237G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD95-0176A MD237G2 (en) 1995-01-20 1995-01-20 Hydrogel "Enzaprogel" for collum uterus maturing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD95-0176A MD237G2 (en) 1995-01-20 1995-01-20 Hydrogel "Enzaprogel" for collum uterus maturing

Publications (2)

Publication Number Publication Date
MD237F1 MD237F1 (en) 1995-07-31
MD237G2 true MD237G2 (en) 1995-12-31

Family

ID=19738636

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0176A MD237G2 (en) 1995-01-20 1995-01-20 Hydrogel "Enzaprogel" for collum uterus maturing

Country Status (1)

Country Link
MD (1) MD237G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD335Z (en) * 2010-11-19 2011-10-31 Родика КАТРИНИЧ Method for preparing the neck of uterus for induction of delivery in pregnants with prolonged pregnancy

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Абрамченко В.В., Богдашкин Н.Г. Простагландины и репродуктивная система женщины. Киев. Здоровье. 1988, с 84-86 *
Пайор А., Кази З., Тарамвелди Т., Шиклоши Д. Расширяющее действие простагландина F 2 alfa на шейку матки. Акушерство и гинекология. 1989. № 5, с.67-68 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD335Z (en) * 2010-11-19 2011-10-31 Родика КАТРИНИЧ Method for preparing the neck of uterus for induction of delivery in pregnants with prolonged pregnancy

Also Published As

Publication number Publication date
MD237F1 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
DE68928897D1 (en) METHOD AND SYSTEM FOR PREVENTION
AU3284984A (en) Pharmaceutical compositions for the transdermal application of active ingredients
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
NZ308293A (en) Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
HUT68498A (en) L-dopa ester compositions and process to prepare them
EP0386960A3 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
WO1989007959A1 (en) Occlusive body for administering a physiologically active substance
AU1537095A (en) Therapeutic agents containing thyroid hormones
CA2114014A1 (en) Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
GEP20002297B (en) Alpha-Substituted Pyrimidine-Thioalhyl and Alkyl-Ether Compounds, Method for Treatment of Individual Infected with the Immunodeficiency Virus
EP0508488A3 (en) Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
EP0045617A3 (en) Pharmaceutical composition
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
BE898749A (en) NEW PROCESS FOR THE PREPARATION OF GALENIC FORMS USEFUL IN PARTICULAR IN THERAPEUTICS, DIETETICS, COSMETICS AND DIAGNOSIS
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
TR199701294T1 (en) Composition consisting of amoxicillin and clavulanic acid.
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
ES526928A0 (en) PROCEDURE FOR THE MANUFACTURE OF CONTROLLED RELEASE TABLETS
EP0535237A4 (en) Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same
AU1458495A (en) Application of riluzole in the treatment of mitochondrial diseases
MD237G2 (en) Hydrogel "Enzaprogel" for collum uterus maturing
IE801402L (en) Gastric acid neutralizing agents
KR880007068A (en) Use of 13-cis retinoic acid